Financial statements Producencka Centrala Farmaceutyczna Procefar
Cash inflows of PRODUCENCKA CENTRALA FARMACEUTYCZNA PROCEFAR
|
Year
|
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
|---|---|---|---|---|---|---|
| Net cash from operating expenses | 1 913 843,85 | 13 298 119,98 | -4 503 909,91 | 3 748 912,80 | 20 640 251,58 | -9 729 155,00 |
| Net cash flow from investing activities | -606 135,64 | -677 035,68 | -1 254 730,92 | -7 710 655,84 | -16 428 262,10 | -695 757,08 |
| Net cash flow from financial activities | -1 176 040,54 | -758 220,89 | -804 120,58 | -221 514,07 | -2 135 293,79 | 9 220 021,65 |
| Total net cash flow | 131 667,67 | 11 862 863,41 | -6 562 761,41 | -4 183 257,11 | 2 076 695,69 | -1 204 890,43 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.